HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/08/2013 -- Bank of America (NYSE:BAC) has settled its dispute with Fannie Mae regarding residential mortgage loans sold to the latter around the time leading up to the 2008 financial crisis. Bank of America will buy back some of those loans for $6.75 billion and also make a payment of $3.6 billion payment. It also sold the servicing rights on 2 million residential mortgage loans with an aggregate unpaid principal balance of $306 billion. “Together, these agreements are a significant step in resolving our remaining legacy mortgage issues, further streamlining and simplifying the company and reducing expenses over time,” said Bank of America CEO Brian Moynihan.
How Should Investors React To BAC Now? CHECK HERE
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer (NSCLC) in 121 patients. The review was prompted by the discovery of vial coding discrepancies while preparing for an end of Phase II meeting with the FDA. The internal review included a thorough operational review of multiple third-party vendor operations at sites worldwide, testing of investigational product used in the trial, additional patient sample testing to determine drug levels and a review of immunogenicity testing results from the trial.
Are these stocks a buy or sell? Free Sign Up Here For Actual Advice
Cisco (NASDAQ:CSCO) recently announced that the company plans to double its revenue from software, which is currently at $6 billion. CEO John Chambers said the growth will be mostly organic but will include some acquisitions. Cisco’s original business of routers and switches currently generates almost half of its total revenue. Cisco has already entered in the areas of cloud computing, data centers, and applications. The company is aiming for eventually transforming itself into an all-round IT player in the "Internet of Things."
Receive The Update Via Email About CSCO: Free Sign Up Here
Shares Alcatel Lucent SA (ADR) (NYSE:ALU) surged by 18 cents or 12.33% to $1.64 in Friday’s session after UBS, the financial services company upgraded its rating on the company’s stock from underperform to neutral based on the company securing a refinancing deal with Goldman Sachs and Credit Suisse worth $2.1 billion, which is to be utilized for paying down its soon-to-mature debts, and to help pay for its restructuring plans.
Should Investors Buy ALU After The Recent Fall? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to loose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)